Inventor · disambiguated record
Ole Olsen
Also filed as: OLSEN OLE · OLSEN OLE A
33 granted patents·16 pending applications·130 citations·filing 2003–2025
97Inventor score
Files withTHERACLONE SCIENCES INC22SYSTIMMUNE INC11GRANDEA III ANDRES G4GRANDEA III ANDRES3OLSEN OLE3
Top patents by PatentIndex Score
49 records- 0197US11192941B2Multi-valent human immunodeficiency virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2020·Granted Dec 7, 2021·4 cites·20 claims
- 0296US12410243B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2023·Granted Sep 9, 2025·2 cites·16 claims
- 0396US10087239B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2016·Granted Oct 2, 2018·14 cites·7 claims
- 0495US9464131B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2013·Granted Oct 11, 2016·18 cites·4 claims
- 0592US9051362B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityCHAN-HUI PO-YING·Filed 2010·Granted Jun 9, 2015·14 cites·20 claims
- 0691US12312396B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2024·Granted May 27, 2025·0 cites·32 claims
- 0791US11319362B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2019·Granted May 3, 2022·3 cites·44 claims
- 0890US12029761B2Guidance and Navigation Control proteins and method of making and using thereofSYSTIMMUNE INC·Filed 2019·Granted Jul 9, 2024·6 cites·21 claims
- 0990US8916160B2Compositions and methods for the therapy and diagnosis of influenzaGRANDEA III ANDRES G·Filed 2012·Granted Dec 23, 2014·11 cites·3 claims
- 1090US8057796B2Compositions and methods for the therapy and diagnosis of influenzaGRANDEA III ANDRES·Filed 2008·Granted Nov 15, 2011·14 cites·11 claims
- 1189US10570191B2Multi-valent human immunodeficiency virus antigen binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2016·Granted Feb 25, 2020·7 cites·14 claims
- 1288US11787863B2Multi-specific antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted Oct 17, 2023·6 cites·16 claims
- 1388US8114402B2Compositions and methods for the therapy and diagnosis of influenzaGRANDEA III ANDRES·Filed 2010·Granted Feb 14, 2012·6 cites·10 claims
- 1486US12018067B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2023·Granted Jun 25, 2024·0 cites·29 claims
- 1585US10865234B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Dec 15, 2020·1 cites·7 claims
- 1683US10836811B2Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodyTHERACLONE SCIENCES INC·Filed 2017·Granted Nov 17, 2020·1 cites·4 claims
- 1782US8460671B2Compositions and methods for the therapy and diagnosis of influenzaGRANDEA III ANDRES·Filed 2011·Granted Jun 11, 2013·5 cites·1 claims
- 1882US8268309B2Compositions and methods for the therapy and diagnosis of cytomegalovirusOLSEN OLE·Filed 2011·Granted Sep 18, 2012·3 cites·10 claims
- 1981US10407493B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2019·Granted Sep 10, 2019·1 cites·20 claims
- 2080US8974788B2Compositions and methods for the therapy and diagnosis of influenzaGRANDEA III ANDRES G·Filed 2010·Granted Mar 10, 2015·4 cites·14 claims
- 2179US11845789B2Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodiesTHERACLONE SCIENCES INC·Filed 2021·Granted Dec 19, 2023·0 cites·15 claims
- 2279US8900590B2Anti-hemagglutinin antibody compositions and methods of use thereofOLSEN OLE·Filed 2011·Granted Dec 2, 2014·5 cites·7 claims
- 2378US12384850B2Guidance and navigation control proteins and method of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted Aug 12, 2025·1 cites·13 claims
- 2478US11518815B2Anti-ROR1 antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted Dec 6, 2022·1 cites·11 claims
- 2578US2025320281A1Methods of treating hiv-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (hiv-1) gp120-specific monoclonal antibodiesINT AIDS VACCINE INITIATIVE INC·Filed 2025·Application pending·0 cites
- 2677US7982012B2Compositions and methods for the therapy and diagnosis of cytomegalovirusTHERACLONE SCIENCES INC·Filed 2009·Granted Jul 19, 2011·1 cites·11 claims
- 2776US11584789B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2020·Granted Feb 21, 2023·0 cites·31 claims
- 2873US8852594B2Compositions and methods for the therapy and diagnosis of cytomegalovirus infectionsOLSEN OLE·Filed 2012·Granted Oct 7, 2014·1 cites·4 claims
- 2972US2025376531A9Anti-4-1bb antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2023·Application pending·0 cites
- 3069US10239934B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2018·Granted Mar 26, 2019·0 cites·14 claims
- 3169US2023322920A1Multi-specific antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2023·Application pending·0 cites
- 3268US8858948B2Compositions and methods for the therapy and diagnosis of influenzaGRANDEA III ANDRES G·Filed 2010·Granted Oct 14, 2014·1 cites·14 claims
- 3365US2015191531A1Compositions and methods for the therapy and diagnosis of cytomegalovirus infectionsTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 3464US2024279333A1Multi-specific antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2023·Application pending·0 cites
- 3562US11987635B2Anti-4-1BB antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted May 21, 2024·0 cites·6 claims
- 3662US2014135480A1Compositions and Methods for the Therapy and Diagnosis of InfluenzaTHERACLONE SCIENCES INC·Filed 2013·Application pending·0 cites
- 3760US9920111B2Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activityTHERACLONE SCIENCES INC·Filed 2015·Granted Mar 20, 2018·0 cites·8 claims
- 3857US2015104459A1Compositions and Methods for the Therapy and Diagnosis of InfluenzaTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 3957US2015086555A1Anti-Hemagglutinin Antibody Compositions and Methods of Use ThereofTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 4056US11649286B2Tri-specific antibodiesSYSTIMMUNE INC·Filed 2018·Granted May 16, 2023·0 cites·17 claims
- 4156US2015098948A1Compositions And Methods For The Therapy And Diagnosis Of InfluenzaTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 4254US11535667B2Anti-CD3 antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Granted Dec 27, 2022·0 cites·17 claims
- 4352US2013158238A1Compositions and Methods for the Therapy and Diagnosis of InfluenzaTHERACLONE SCIENCES INC·Filed 2013·Application pending·0 cites
- 4452US2014363441A1Compositions and methods for the therapy and diagnosis of influenzaTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 4551US2011033476A1Compositions and methods for the therapy and diagnosis of influenzaTHERACLONE SCIENCES INC·Filed 2010·Application pending·0 cites
- 4648US2015152166A1Compositions and methods for the therapy and diagnosis of cytomegalovirusTHERACLONE SCIENCES INC·Filed 2014·Application pending·0 cites
- 4745US2012315277A1Compositions and Methods for the Therapy and Diagnosis of InfluenzaGRANDEA III ANDRES G·Filed 2012·Application pending·0 cites
- 4842US2007010433A1Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive diseaseSEMA APS·Filed 2003·Application pending·0 cites
- 4942US2020157224A1Multi-specific antibodies and methods of making and using thereofSYSTIMMUNE INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ole Olsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →